JESSE ROBINSON: Open Payments
NPI 1760110266 · CAMPBELLSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,313 in 86 payments from 14 companies in 2025. Trend: 2023 $1,416 · 2024 $1,581 · 2025 $1,313
Food & beverage: $1,313
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $464 |
| PFIZER INC. | 22 | $269 |
| Lundbeck LLC | 5 | $114 |
| Lilly USA, LLC | 4 | $93 |
| UCB, Inc. | 3 | $79 |
| Eisai Inc. | 3 | $63 |
| Amneal Pharmaceuticals LLC | 3 | $50 |
| SK Life Science, Inc. | 2 | $46 |
| Neurelis, Inc. | 2 | $32 |
| Biogen, Inc. | 1 | $30 |
Products named: QULIPTA, NURTEC ODT, UBRELVY, VYEPTI, Leqembi, Rystiggo, AMYVID, CREXONT.
Industry payments across KY — which companies pay providers there.
